BioCentury
ARTICLE | Company News

Genaissance, Millennium HAP licensing deal

January 7, 2003 8:00 AM UTC

MLNM received a multi-year, non-exclusive license to GNSC's HAP technology, which is based on haplotype markers. MLNM will pay license fees. ...